Connectlife Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -33.79%
- Profit Growth -42.23%
- Ebitda 971.91%
- Net Worth 22.35%
- Total Assets 25.22%
About Connectlife Pharma
Connectlife Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 December 2018 (Six years and two months 8 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kanhaiya Keshri and Amar Keshri serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2018PTC343132
- Company No.
343132
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Connectlife Pharma Private Limited offer?
Connectlife Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Dietary Supplements, Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Connectlife Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanhaiya Keshri  | Director Appointed In Casual Vacancy | 22-Mar-2019 | Current |
| Amar Keshri | Director | 17-Dec-2018 | Current |
Financial Performance of Connectlife Pharma.
Connectlife Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.79% decrease. The company also saw a substantial fall in profitability, with a 42.23% decrease in profit. The company's net worth Soared by an impressive increase of 22.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Connectlife Pharma?
Unlock access to Connectlife Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kesar Vaccine Distributors Private LimitedAmar Keshri is a mutual person
- Kalsham Food Overseas Private Limited
Amar Keshri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Connectlife Pharma?
Unlock and access historical data on people associated with Connectlife Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Connectlife Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Connectlife Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
